MD

Pediatrix Medical Group, Inc. - 10-K Summary (Fiscal Year Ended Dec 31, 1997)

Business Context and Reporting Period

This Form 10-K covers the fiscal year ended December 31, 1997. Pediatrix Medical Group, Inc. (PMG) is the nation's leading provider of physician management services to hospital-based Neonatal Intensive Care Units (NICUs), Pediatric Intensive Care Units (PICUs), and pediatric departments. As of year-end 1997, the Company operated in 20 states and Puerto Rico, managing over 100 hospital-based units and one perinatology practice with approximately 260 physicians. The Company's strategy focuses on growth through acquisitions and the development of regional networks to strengthen negotiating power with managed care organizations.

Key Financial Metrics

Liquidity: The Company maintained a $75.0 million unsecured revolving credit facility with no outstanding balance as of December 31, 1997. Cash and marketable securities totaled approximately $45.7 million.

Material Changes vs. Prior Period

• Revenue Growth: Net patient service revenue increased 59.4% to $128.9 million. Approximately 98.8% of this increase ($47.5 million) was attributable to new units acquired or added through internal marketing. Same-unit growth was 1.2%.
• Acquisitions: The Company completed ten acquisitions in 1997, adding 28 NICUs, utilizing approximately $59.0 million in cash. This drove a 155.5% increase in depreciation and amortization expenses due to goodwill amortization.
• Expenses: Salaries and benefits rose 54.5% to $81.5 million, primarily due to hiring physicians for new units. Supplies and other operating expenses increased 55.9% to $9.8 million.
• Profitability: Despite higher expenses, operating income grew 64.8% to $33.1 million, and the operating margin improved from 24.8% to 25.7% due to volume increases without comparable overhead growth.

Outlook, Risks, and Management Commentary

Outlook and Strategy: Management intends to continue expanding through acquisitions of neonatal and perinatal physician groups and developing regional networks. The Company plans to integrate perinatology services further and explore obstetrics. Funds from operations and the credit facility are deemed sufficient for working capital and acquisitions for the next 12 months.

Risks and Contingencies:

• Regulatory Environment: Approximately 22% of revenue is derived from government programs (Medicaid). Changes in reimbursement rates or managed care shifts could materially impact results. The Company faces risks related to the Anti-Kickback Statute and Stark II self-referral laws.
• Corporate Practice of Medicine: State laws generally prohibit corporations from practicing medicine. PMG utilizes Professional Association (PA) Contractors to mitigate this risk, but regulatory challenges regarding fee-splitting or corporate practice could force restructuring.
• Acquisition Risks: Future growth depends on identifying and integrating acquisitions successfully. Failure to retain key personnel or integrate new units could adversely affect operations.
• Legal Proceedings: The Company is under IRS examination for tax years 1992-1994 regarding deductions that could result in $4.5 million in additional taxes, though management believes the outcome will not be material. Medical malpractice claims are ongoing but expected to be covered by insurance.

Investor Verification Checklist

• Verify the sustainability of the 59.4% revenue growth rate, noting that 98.8% was driven by acquisitions rather than organic same-unit growth.
• Monitor the impact of Medicaid reimbursement rates, which constitute 22% of revenue, on future margins.
• Assess the status of the IRS examination regarding the potential $4.5 million tax liability.
• Review the Company's ability to successfully integrate the 28 new NICUs acquired in 1997 and the 8 practices acquired in early 1998.
• Confirm the Company's compliance with state laws regarding the corporate practice of medicine and fee-splitting arrangements with PA Contractors.